E. Durcan Et Al. , "Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia," JOURNAL OF DIABETES , vol.14, no.4, pp.236-246, 2022
Durcan, E. Et Al. 2022. Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia. JOURNAL OF DIABETES , vol.14, no.4 , 236-246.
Durcan, E., ÖZKAN, S., Saygi, H. I., Dincer, M. T., Korkmaz, O. P., Sahin, S., ... KARACA, C.(2022). Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia. JOURNAL OF DIABETES , vol.14, no.4, 236-246.
Durcan, Emre Et Al. "Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia," JOURNAL OF DIABETES , vol.14, no.4, 236-246, 2022
Durcan, Emre Et Al. "Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia." JOURNAL OF DIABETES , vol.14, no.4, pp.236-246, 2022
Durcan, E. Et Al. (2022) . "Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia." JOURNAL OF DIABETES , vol.14, no.4, pp.236-246.
@article{article, author={Emre Durcan Et Al. }, title={Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia}, journal={JOURNAL OF DIABETES}, year=2022, pages={236-246} }